O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease

10.1007/s12017-019-08584-0

Saved in:
Bibliographic Details
Main Authors: Park, Jinsu, Lai, Mitchell KP, Arumugam, Thiruma V, Jo, Dong-Gyu
Other Authors: DEPT OF PHARMACOLOGY
Format: Review
Language:English
Published: HUMANA PRESS INC 2021
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/188340
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-188340
record_format dspace
spelling sg-nus-scholar.10635-1883402024-04-04T01:11:40Z O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease Park, Jinsu Lai, Mitchell KP Arumugam, Thiruma V Jo, Dong-Gyu DEPT OF PHARMACOLOGY PHYSIOLOGY Science & Technology Life Sciences & Biomedicine Neurosciences Neurosciences & Neurology Alzheimer's disease O-GlcNAcylation O-GlcNAc Glucose metabolism Neurodegeneration LINKED N-ACETYLGLUCOSAMINE AMYLOID PRECURSOR PROTEIN FRUCTOSE 6-PHOSPHATE AMIDOTRANSFERASE AMYOTROPHIC-LATERAL-SCLEROSIS GAMMA-SECRETASE CLEAVAGE TYPE-2 DIABETES-MELLITUS BRAIN INSULIN-RESISTANCE TRANSGENIC MOUSE MODEL GLCNAC TRANSFERASE PARKINSONS-DISEASE 10.1007/s12017-019-08584-0 NEUROMOLECULAR MEDICINE 22 2 171-193 2021-04-05T09:17:57Z 2021-04-05T09:17:57Z 2020-06-01 2021-04-03T05:03:12Z Review Park, Jinsu, Lai, Mitchell KP, Arumugam, Thiruma V, Jo, Dong-Gyu (2020-06-01). O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease. NEUROMOLECULAR MEDICINE 22 (2) : 171-193. ScholarBank@NUS Repository. https://doi.org/10.1007/s12017-019-08584-0 15351084 15591174 https://scholarbank.nus.edu.sg/handle/10635/188340 en HUMANA PRESS INC Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Neurosciences
Neurosciences & Neurology
Alzheimer's disease
O-GlcNAcylation
O-GlcNAc
Glucose metabolism
Neurodegeneration
LINKED N-ACETYLGLUCOSAMINE
AMYLOID PRECURSOR PROTEIN
FRUCTOSE 6-PHOSPHATE AMIDOTRANSFERASE
AMYOTROPHIC-LATERAL-SCLEROSIS
GAMMA-SECRETASE CLEAVAGE
TYPE-2 DIABETES-MELLITUS
BRAIN INSULIN-RESISTANCE
TRANSGENIC MOUSE MODEL
GLCNAC TRANSFERASE
PARKINSONS-DISEASE
spellingShingle Science & Technology
Life Sciences & Biomedicine
Neurosciences
Neurosciences & Neurology
Alzheimer's disease
O-GlcNAcylation
O-GlcNAc
Glucose metabolism
Neurodegeneration
LINKED N-ACETYLGLUCOSAMINE
AMYLOID PRECURSOR PROTEIN
FRUCTOSE 6-PHOSPHATE AMIDOTRANSFERASE
AMYOTROPHIC-LATERAL-SCLEROSIS
GAMMA-SECRETASE CLEAVAGE
TYPE-2 DIABETES-MELLITUS
BRAIN INSULIN-RESISTANCE
TRANSGENIC MOUSE MODEL
GLCNAC TRANSFERASE
PARKINSONS-DISEASE
Park, Jinsu
Lai, Mitchell KP
Arumugam, Thiruma V
Jo, Dong-Gyu
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
description 10.1007/s12017-019-08584-0
author2 DEPT OF PHARMACOLOGY
author_facet DEPT OF PHARMACOLOGY
Park, Jinsu
Lai, Mitchell KP
Arumugam, Thiruma V
Jo, Dong-Gyu
format Review
author Park, Jinsu
Lai, Mitchell KP
Arumugam, Thiruma V
Jo, Dong-Gyu
author_sort Park, Jinsu
title O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
title_short O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
title_full O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
title_fullStr O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
title_full_unstemmed O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease
title_sort o-glcnacylation as a therapeutic target for alzheimer's disease
publisher HUMANA PRESS INC
publishDate 2021
url https://scholarbank.nus.edu.sg/handle/10635/188340
_version_ 1795374627405430784